Johanna Kellett‐Wright

Efficacy, safety, and immunogenicity of a booster regimen of Ad26.COV2.S vaccine against COVID-19 (ENSEMBLE2): results of a randomised, double-blind, placebo-controlled, phase 3 trial

Karin Hardt, An Vandebosch, Jerald Sadoff et al. · The Lancet Infectious Diseases · 2022 · 88 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +14

Screening for HIV-Associated Neurocognitive Disorder (HAND) in Adults Aged 50 and Over Attending a Government HIV Clinic in Kilimanjaro, Tanzania. Comparison of the International HIV Dementia Scale (IHDS) and IDEA Six Item Dementia Screen

Johanna Kellett‐Wright, Aidan Flatt, Patrick Eaton et al. · AIDS and Behavior · 2020 · 29 citations · Full text

Medicine, Geriatric Medicine, Neurology +17

Prevalence and 1-year incidence of HIV-associated neurocognitive disorder (HAND) in adults aged ≥50 years attending standard HIV clinical care in Kilimanjaro, Tanzania

Aidan Flatt, Tom Gentry, Johanna Kellett‐Wright et al. · International Psychogeriatrics · 2021 · 27 citations · Full text

Public Health, Community Health, Geriatric Medicine +17

Risk factors for symptomatic <scp>HIV</scp>‐associated neurocognitive disorder in adults aged 50 and over attending a <scp>HIV</scp> clinic in Tanzania

Patrick Eaton, Thomas Lewis, Johanna Kellett‐Wright et al. · International Journal of Geriatric Psychiatry · 2020 · 23 citations · Full text

Public Health, Community Health, Neurology +17